Related references
Note: Only part of the references are listed.Amyloid Imaging in Mild Cognitive Impairment Subtypes
David A. Wolk et al.
ANNALS OF NEUROLOGY (2009)
Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects
E. C. Mormino et al.
BRAIN (2009)
Comparison of 18F-FDG and PiB PET in Cognitive Impairment
Val J. Lowe et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease
A. Drzezga et al.
NEUROLOGY (2009)
Relationships between biomarkers in aging and dementia
W. J. Jagust et al.
NEUROLOGY (2009)
Conversion of amyloid positive and negative MCI to AD over 3 years An 11C-PIB PET study
A. Okello et al.
NEUROLOGY (2009)
Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
Eric M. Reiman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease
Ahmadul Kadir et al.
ANNALS OF NEUROLOGY (2008)
Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
Howard Jay Aizenstein et al.
ARCHIVES OF NEUROLOGY (2008)
IIC PiB and structural MRI provide complementary information in imaging of Alzheimers disease and amnestic mild cognitive impairment
Clifford R. Jack et al.
BRAIN (2008)
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
Milos D. Ikonomovic et al.
BRAIN (2008)
Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease
Yi Li et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B
Cyrus A. Raji et al.
JOURNAL OF NEUROSCIENCE METHODS (2008)
Voxel-based analysis of 11C-PIB scans for diagnosing Alzheimer's disease
Arthur Mikhno et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias
Lisa Mosconi et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
PET imaging of amyloid deposition in patients with mild cognitive impairment
Anton Forsberg et al.
NEUROBIOLOGY OF AGING (2008)
Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease
Alexander Drzezga et al.
NEUROIMAGE (2008)
A beta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease
V. L. Villemagne et al.
NEUROPSYCHOLOGIA (2008)
β-amyloid imaging and memory in non-demented individuals:: evidence for preclinical Alzheimer's disease
Kerryn E. Pike et al.
BRAIN (2007)
Impact of amyloid imaging on drug development in Alzheimer's disease
Chester A. Mathis et al.
NUCLEAR MEDICINE AND BIOLOGY (2007)
Imaging β-amyloid burden in aging and dementia
C. C. Rowe et al.
NEUROLOGY (2007)
PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment
N. M. Kemppainen et al.
NEUROLOGY (2007)
11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration
G. D. Rabinovici et al.
NEUROLOGY (2007)
Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease
Steven Ng et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Hippocampal and entorhinal atrophy in mild cognitive impairment - Prediction of Alzheimer disease
D. P. Devanand et al.
NEUROLOGY (2007)
Molecular imaging with Pittsburgh compound B confirmed at autopsy - A case report
Brian J. Bacskai et al.
ARCHIVES OF NEUROLOGY (2007)
Amyloid, hypometabolism, and cognition in Alzheimer disease - An [11C]PIB and [18F]FDG PET study
P. Edison et al.
NEUROLOGY (2007)
In vivo quantification of serotonin transporters using [C-11]DASB and positron emission tomography in humans: modeling considerations
R. Todd Ogden et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
Henry Engler et al.
BRAIN (2006)
Evaluation of voxel-based methods for the statistical analysis of PIBPET amyloid imaging studies in Alzheimer's disease
Scott K. Ziolko et al.
NEUROIMAGE (2006)
[11]PIB in a nondemented population -: Potential antecedent marker of Alzheimer disease
M. A. Mintun et al.
NEUROLOGY (2006)
Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B
JC Price et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Amyloid plaque imaging agent [C-11]-6-OH-BTA-1:: biodistribution and radiation dosimetry in baboon
Ramin V. Parsey et al.
NUCLEAR MEDICINE COMMUNICATIONS (2005)
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
WE Klunk et al.
ANNALS OF NEUROLOGY (2004)
Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study
A Drzezga et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Mild cognitive impairment -: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?
G Chételat et al.
NEUROLOGY (2003)
Positron emission tomography in evaluation of dementia - Regional brain metabolism and long-term outcome
DHS Silverman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Imaging human mesolimbic dopamine transmission with positron emission tomography:: I.: Accuracy and precision of D2 receptor parameter measurements in ventral striatum
O Mawlawi et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2001)
Practice parameter: Diagnosis of dementia (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology
DS Knopman et al.
NEUROLOGY (2001)
Share Paper
